FDA
Rizatriptan Benzoate
The FDA lists this product in 50 strengths and forms.
Composition
- Active ingredients
- RIZATRIPTAN BENZOATE EQ 5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RIZATRIPTAN BENZOATE EQ 5MG BASE · Tablet, orally disintegratingANDA203146-001 · Prescription
- RIZATRIPTAN BENZOATE EQ 10MG BASE · Tablet, orally disintegratingANDA203146-002 · Prescription
- RIZATRIPTAN BENZOATE EQ 10MG BASE · TabletANDA200482-002 · Discontinued
- RIZATRIPTAN BENZOATE EQ 5MG BASE · TabletANDA200482-001 · Discontinued
- RIZATRIPTAN BENZOATE EQ 5MG BASE · Tablet, orally disintegratingANDA203478-001 · Discontinued
- RIZATRIPTAN BENZOATE EQ 10MG BASE · Tablet, orally disintegratingANDA203478-002 · Discontinued
- RIZATRIPTAN BENZOATE EQ 10MG BASE · TabletANDA201967-002 · Discontinued
- RIZATRIPTAN BENZOATE EQ 5MG BASE · TabletANDA201967-001 · Discontinued
- RIZATRIPTAN BENZOATE EQ 5MG BASE · Tablet, orally disintegratingANDA204722-001 · Prescription
- RIZATRIPTAN BENZOATE EQ 10MG BASE · Tablet, orally disintegratingANDA204722-002 · Prescription
- RIZATRIPTAN BENZOATE EQ 10MG BASE · Tablet, orally disintegrating
At a glance
- Brand name
- Rizatriptan Benzoate
- Route
- Oral
- Dosage form
- Tablet, orally disintegrating
- Applicant
- Chartwell RX
- Status
- Discontinued
- FDA approval
- 1 Jul 2013
- Application
- ANDA078739-001